Gordon Baltzer has over 30 years of experience in the pharmaceutical and healthcare industries. Mr. Baltzer has held a variety of positions in these fields, including Principal and Executive Vice President of River Oaks Imaging and Diagnostic, a private network of multi-modality diagnostic imaging centers in Houston, Texas; Chief Financial Officer and Vice President of Business Development for Royce Laboratories, Inc., a publicly-held pharmaceutical company in Miami, Florida; Director of Financial Planning and Analysis for Apotex, Inc., Canada’s largest producer of generic pharmaceuticals, with head offices in Toronto, Ontario, Canada; and Board Member, Secretary and Treasurer of Methapharm Inc., a privately held brand-name pharmaceutical company with offices in Brantford, Ontario and Coral Springs, Florida.
He also has large public audit experience with BDO and KPMG in Toronto, Canada. He earned his Bachelor of Arts degree from The University of Western Ontario in London, Ontario, Canada and his Chartered Accountant designation from the Canadian Institute of Charted Accountants.
In addition to his role as Chairman and CEO of York Instruments Ltd., Mr. Baltzer serves as Chairman of The MEI Healthcare Group, a privately-held healthcare development company focused on the development, financing and management of diagnostic imaging and radiation therapy facilities in the United States and internationally.